CORVUS PHARMACEUTICALS
8.8000
07-November-24 14:59:59
15 minutes delayed
Stocks
+0.0200
+0.23%
Today's range
8.4300 - 9.1000
ISIN
N/A
Source
NASDAQ
-
Corvus Pharmaceuticals Appoints Dr. James Rosenbaum Senior Vice President of Research
21 Jul 2022 15:05:01 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Program Updates at R&D Symposium
10 May 2022 06:30:02 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
05 May 2022 15:05:03 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Host R&D Symposium on May 10, 2022 in New York
26 Apr 2022 06:30:00 By Nasdaq GlobeNewswire
-
10 Mar 2022 15:05:01 By Nasdaq GlobeNewswire
-
03 Mar 2022 15:30:00 By Nasdaq GlobeNewswire
-
13 Jan 2022 17:30:00 By Nasdaq GlobeNewswire
-
13 Dec 2021 08:00:00 By Nasdaq GlobeNewswire
-
12 Nov 2021 06:00:02 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
10 Nov 2021 15:05:00 By Nasdaq GlobeNewswire
-
02 Nov 2021 15:05:01 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financial Results
01 Nov 2021 15:05:00 By Nasdaq GlobeNewswire
-
27 Oct 2021 15:05:01 By Nasdaq GlobeNewswire
-
22 Sep 2021 05:00:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
07 Sep 2021 15:05:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818 in China
16 Aug 2021 16:00:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results
02 Aug 2021 15:05:01 By Nasdaq GlobeNewswire
-
15 Jul 2021 15:05:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
25 May 2021 15:05:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Completes Sale of $10 Million Through Its ATM Program
05 May 2021 08:00:01 By Nasdaq GlobeNewswire